<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>In the years 1991 and 1992, 203 teams in 26 European countries performed 11026 BMT procedures: 4841 allografts and 6185 autografts; 10263 (93%) were performed in those 12 countries which did at least 100 transplants in total and five transplants per 1 million inhabitants per year during this 2-year period </plain></SENT>
<SENT sid="1" pm="."><plain>Indications for these 10263 BMT were <z:hpo ids='HP_0001909'>leukemia</z:hpo> in 5080 patients (3294 allo-BMT, 1786 auto-BMT), lymphopro-liferative disorders in 3177 patients (329 allo-BMT, 2848 auto-BMT), <z:e sem="disease" ids="C0280100" disease_type="Neoplastic Process" abbrv="">solid tumors</z:e> in 1236 patients (18 allogeneic-BMT), 1218 autologous-BMT), <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> in 305 patients and <z:e sem="disease" ids="C0852325" disease_type="Disease or Syndrome" abbrv="">hemoglobinopathies</z:e> or inborn errors of disease in 465 patients (456 allogeneic-BMT, 9 autologous-BMT) </plain></SENT>
<SENT sid="2" pm="."><plain>The proportion of allogeneic- and autologous-BMT, the main indications and the timing (first complete remission versus later stages) were compared between these 12 countries </plain></SENT>
<SENT sid="3" pm="."><plain>Differences and similarities can be observed in <z:hpo ids='HP_0000001'>all</z:hpo> three aspects </plain></SENT>
<SENT sid="4" pm="."><plain>They underline previously described differences in Europe which can partially be ascribed to different patient populations but may also be caused by divergent medical opinions </plain></SENT>
</text></document>